| Date | Speaker | Institution | HCC Sponsoring Program |
| 2013 | | | |
| March 7, 2013 | Tony Futerman, PhD | Weizmann Institute for Research | Lipid Signaling in Cancer |
| March 21, 2013 | Lewis A. Chodosh, PhD, MD | University of Pennsylvania | Cancer Genes & Molecular Regulation |
| March 22, 2013 | Drew M. Pardoll, MD, PhD | The Johns Hopkins University | Cancer Immunology |
| April 4-5, 2013 | Christopher E. Turner, PhD | State University of New York, Syracuse | Developmental Cancer Therapeutics |
| April 26, 2013 | David Feldman, MD | Stanford University | Cancer Prevention & Control |
| May 3, 2013 | Miles A. Brown, MD | Harvard University | Cancer Genes & Molecular Regulation |
| May 31, 2013 | Robert Clarke, PhD | Georgetown University Medical Center | Developmental Cancer Therapeutics |
| Date | Time/Location | Speaker | Institution | HCC Sponsoring Program |
| 2013 | | | | |
| Jan. 10, 2013 | Noon/HCC120 | Richard Kolesnick, PhD | Memorial Sloan Kettering Cancer Center | Lipid Signaling in Cancer |
| Jan.18, 2013 | Noon/HCC120 | Ramaswamy Govindan, MD | Washington University | Mark R. Green Visiting Professorship |
| 2012 | | | | |
| Jan. 13, 2012 | Noon/HCC120 | John A. Baron, MD | UNC at Chapel Hill | Cancer Prevention & Control |
| Jan. 20, 2012 | Noon/HCC120 | Thomas Lynch, MD | Yale University Cancer Center | Mark R. Green Visiting Professorship |
| Feb. 2, 2012 | Noon/HCC120 | Peter S. Nelson, MD | Fred Hutchinson Cancer Research Center | Cancer Genes & Molecular Regulation |
| Feb. 23, 2012 | Noon/HCC120 | Jennifer Lippincott-Schwartz, PhD | National Institutes of Health | Lipid Signaling in Cancer |
| March 29, 2012 | Noon/HCC120 | Allen J. Ebens, PhD | Genentech | Special Seminar |
| April 5, 2012 | Noon/HCC120 | Maarten van Lohuizen, PhD | Maarten van Lohuizen, PhD | Special Seminar |
| April 13, 2012 | Noon/HCC120 | Joe Lipstick, MD, PhD | Stanford University | Cancer Genes & Molecular Regulation |
| May 3, 2012 | Noon/HCC120 | Patricia A. Ganz, MD | Jonsson Comprehensive Cancer Center | Cancer Prevention & Control |
| May 17, 2012 | Noon/HCC120 | Levi Garraway, MD, PhD | Dana Farber Cancer Institute | Special Seminar |
| December 6, 2012 | Noon/HCC120 | Myriam Gorospe, PhD | National Institutes of Health | Cancer Genes & Molecular Regulation |
| 2011 | | | | |
| Jan. 21, 2011 | Noon/HCC120 | Dr. Everett Vokes | University of Chicago | Mark R. Green Visiting Professorship |
| Feb. 11, 2011 | Noon/HCC120 | Dr. Susan Cole | Queens University, Ontario | Developmental Cancer Therapeutics |
| April 15, 2011 | Noon/HCC120 | Dr. Michael Caligiuri | Ohio State University | Hematological Malignancies |
| May 6, 2011 | Noon/HCC120 | Dr. Jamie Ostroff | Memorial Sloan Kettering | Cancer Prevention & Control |
| May 12, 2011 | Noon/HCC120 | Dr. Yung-Chi Chen | Yale University | Hematological Malignancies |
| Sept. 29, 2011 | Noon/HCC120 | Dr. Dean P. Jones | Emory University | Developmental Cancer Therapeutics |
| Nov. 3, 2011 | Noon/HCC120 | Dr. Paul L. Fox | Cleveland Clinic | |
| Nov. 10, 2011 | Noon/HCC120 | Dr. Robert Casero, Jr. | Sidney Kimmel Comprehensive Cancer Center | Developmental Cancer Therapeutics |
| Dec. 8, 2011 | Noon/HCC120 | Dr. Brian Wattenberg | University of Louisville | Lipid Signaling in Cancer |
| Dec. 12, 2011 | 3:00 pm/HCC 124L | Dr. Roderick Beijersbergen | The Netherlands Cancer Institute | Special Seminar |
| 2010 | | | | |
| March 18, 2010 | 11:00 am/120 HCC | Dr. Stephen Baylin | The Johns Hopkins University | Cancer Genes & Molecular Regulation |
| April 8, 2010 | 11:00 am/120 HCC | Dr. Mark Davis | Stanford University | Cancer Immunology |
| April 22, 2010 | 11:00 am/120 HCC | Dr. Frank Meyskens | University of California, Irvine | Cancer Prevention & Control |
| Sept. 9, 2010 | 11:00 am/120 HCC | Dr. Michael Karin | University of California, San Diego | Lipid Signaling in Cancer |
| Sept. 17, 2010 | 11:00 am/120 HCC | Dr. Keith Robertson | Medical College of Georgia | Cancer Genes & Molecular Regulation |
| Oct. 12, 2010 | Noon/HCC120 | Dr. Yang Liu | University of Michigan | Cancer Immunology |
| Oct. 22, 2010 | Noon/HCC120 | Dr. Ralph Sanderson | University of Alabama | Cancer Genes & Molecular Regulation |
| Nov. 12, 2010 | Noon/HCC120 | Dr. Eckard Podak | University of Miami | Cancer Immunology |
| 2009 |
|
|
|
|
| Jan. 15, 2009 | 11:00 am/120 | Dr. Ratna Ray | St. Louis University | Cancer Genes & Molecular Regulation |
| Jan. 23, 2009 | 12Noon/120 | Dr. Danilo Perotti | Ohio State University | Hematological Malignancies |
| March 5, 2009 | 11:00 am/120 | Dr. Kornelia Polyak | Dana-Farber Cancer Institute | Cancer Genes & Molecular Regulation |
| March 19, 2009 | 11:00 am/120 | Dr. Frank Meyskens | UCI Medical Center | Cancer Prevention & Control |
| March 26, 2009 | 11:00 am/120 | Dr. Branimir Sikic | Stanford University | Developmental Cancer Therapeutics |
| June 25, 2009 | 11:00 am/120 | Dr. Licia Rivoltini | Institute National Tumori, Italy | Cancer Immunology |
| Oct. 2, 2009 | 1:00 pm/2 W. Amp. | Dr. Maria Jasin | Memorial Sloan Kettering | Hematological Malignancies |
| Nov. 5, 2009 | 11:00 am/120 | Dr. Constantinos Koumenis | University of Pennsylvania | Developmental Cancer Therapeutics |
2008 |
|
|
|
|
| Dec. 11, 2008 | 11:00 am/120 | Dr. Francis Ali-Osman | Duke University | Developmental Cancer Therapeutics |
| Dec. 9, 2008 | 11:00 am/120 | Dr. Charles Swanton | London Research Institute | Lipid Signaling in Cancer |
| Oct. 16, 2008 | 11:00 am/120 | Dr. Carol Prives | Columbia University | Cancer Genes & Molecular Regulation |
| Oct. 2, 2008 | 11:00 am/120 | Dr. Matthias Theobald | Creveld Clinic at the Univ. Medical Center Utrecht, Netherlands | Cancer Immunology |
| May 29, 2008 | 11:00 am/120 HCC | Dr. Besim Ogretmen | MUSC | Lipid Signaling in Cancer |
| May 22, 2008 | 11:00 am/120 HCC | Dr. Marvella Ford | MUSC | Cancer Prevention & Control |
| May 15, 2008 | 11:00 am/120 HCC | Dr. Carol Prives | Columbia University, NY | Cancer Genes & Molecular Regulation |
| May 8, 2008 | 11:00 am/120 HCC | Dr. Sergey Krupenko | MUSC | Lipid Signaling in Cancer |
| May 1, 2008 | 11:00 am/120 HCC | Dr. Ken Tew | MUSC | Developmental Cancer Therapeutics |
| April 24, 2008 | 11:00 am/120 HCC | Dr. Ruma Banerjee | University of Michigan | Developmental Cancer Therapeutics |
| April 3, 2008 | 11:00 am/120 HCC | Dr. Jean Ford | Johns Hopkins Bloomberg School of Public Health | Cancer Prevention & Control |
| March 27, 2008 | 11:00 am/120 HCC | Dr. Deanne Lathers | MUSC |
|
| March 21, 2008 | 11:00 am/120 HCC | Dr. Zena Werb | University of California, San Francisco | Lipid Signaling in Cancer |
| March 6, 2008 | 11:00 am/120 HCC | Dr. Pierre Van Der Bruggen | Ludwig Institute | Cancer Immunology |
| Feb. 21, 2008 | 11:00 am/120 HCC | Dr. Tilman Heise | MUSC | Lipid Signaling in Cancer |
| Feb. 7, 2008 | 11:00 am/120 HCC | Dr. Charles Smith | MUSC | Developmental Cancer Therapeutics |
| Jan. 31, 2008 | 11:00 am/120 HCC | Dr. Bryan Toole | MUSC | Cancer Genes & Molecular Regulation |
| Jan. 24, 2008 | 11:00 am/120 HCC | Dr. Makio Ogawa | MUSC | Cancer Genes & Molecular Regulation |
| Jan. 28, 2008 | 11:00 am/120 HCC | Dr. Linda Malkas | Indiana University | Developmental Cancer Therapeutics |
| 2007 |
|
|
|
|
| Dec. 13, 2007 | 11:00 am/120 HCC | Dr. Tao Cheng | University of Pittsburgh Cancer Center | Hematologic Malignancies |
| Dec. 6, 2007 | 11:00 am/120 HCC | Dr. Michael Wargovich | MUSC | Developmental Cancer Therapeutics |
| Sept. 27, 2007 | 11:00 am/120 HCC | Dr. Stephen Hecht | University of Minnesota Cancer Center | Cancer Prevention & Control |
| Sept. 20, 2007 | 11:00 am/120 HCC | Dr. Robert Hiatt | University of California, San Francisco | Cancer Prevention & Control |
| Sept. 14, 2007 | 11:00 am/120 HCC | Dr. Jan Schnitzer | Sidney Kimmel Cancer Center | Lipid Signaling in Cancer |
| Sept. 13, 2007 | 11:00 am/120 HCC | Dr. Barbara Wollenberg | University of Munich | Cancer Immunology |
| Sept. 14, 2006 | 12 noon/302 BSB | Dr. Joseph Bertino | Cancer Institute of NJ | Hematological Malignancies |
| Dec. 7, 2006 | 12 noon/120 HCC | Dr. Robert Nagourney | Long Beach Memorial | Developmental Cancer Therapeutics |
| Jan. 11, 2007 | 12 noon/120 HCC | Dr. Silvio Gutkind | National Institutes of Health, NIDCR | Cancer Cell Signalling |
| Jan. 25, 2007 | 12 noon/120 HCC | Dr. Luke Whitesell | Whitehead Institute | Developmental Cancer Therapeutics |
| Feb. 8, 2007 | 11:30 am/120 HCC | Dr. Michael Nishimura | MUSC/Hollings Cancer Center | Cancer Immunology |
| Feb. 22, 2007 | 11:30 am/120 HCC | Dr. Rolf Kiessling | Karolinska Institute, Stockholm | Cancer Immunology |
| March 8, 2007 | 11:30 am/120 HCC | Dr. Lewis Cantley | Harvard University | Lipid Signaling in Cancer |
| March 15, 2007 | 11:30 am/120 HCC | Dr. Judith Campisi | Berkeley National Lab | Cancer Genes & Molecular Regulation |
| March 29, 2007 | 11:30 am/120 HCC | Dr. Dennis Watson | MUSC/Hollings Cancer Center | Cancer Genes & Molecular Regulation |
| April 5, 2007 | 11:30 am/120 HCC | Dr. Steven Rosenzweig | MUSC/Hollings Cancer Center | Lipid Signaling in Cancer |
| April 12, 2007 | 11:30 am/120 HCC | Dr. Dorothy Hatsukami | University of Minnesota | Cancer Prevention and Control |
| April 26, 2007 | 11:30 am/120 HCC | Dr. Judy Karp | The Sidney Kimmel Cancer | Hematological Malignancies |
| May 5, 2007 | 11:30 am/120 HCC | Dr. Anthony Alberg | MUSC/Hollings Cancer Center | Cancer Prevention and Control |
| May 10, 2007 | 11:30 am/120 HCC | Dr. Stephen Hecht | University of Minnesota | Cancer Prevention and Control |
| May 24, 2007 | 11:30 am/120 HCC | Dr. Lisa Coussens | University of California, SF | Cancer Genes & Molecular Regulation |
| May 31, 2007 | 11:30 am/120 HCC | Dr. Craig Slingluff | University of Virginia | Cancer Immunology |